Overview

Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors

Status:
Active, not recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This clinical study evaluated the safety and efficacy of SPH4336 in the treatment of advanced solid tumors.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co., Ltd